TBPH icon

Theravance Biopharma
TBPH

Overview Fund Activity

96 hedge funds and large institutions have $1.22B invested in Theravance Biopharma in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 14 closing their positions.

Holders
96
Holders Change
+3
Holders Change %
+3.23%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
39
Reduced
22
Closed
14
Calls
$245K
Puts
–
Net Calls
+$245K
Net Calls Change
-$457K

Top Buyers

1
WIM
1
Woodford Investment Management
United Kingdom
$315M
2
Morgan Stanley
2
Morgan Stanley
New York
$16M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$102M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$3.56M
5
First Trust Advisors
5
First Trust Advisors
Illinois
$2.24M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$0
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$31.6M
3
CAM
3
Cormorant Asset Management
Massachusetts
$22.6M
4
Millennium Management
4
Millennium Management
New York
$0
5
Deutsche Bank
5
Deutsche Bank
Germany
$1.34M
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
101
Two Sigma Investments
New York
– -$511K -15,656 Closed
OAC
102
OMERS Administration Corp
Ontario, Canada
– -$327K -10,000 Closed
Man Group
103
Man Group
United Kingdom
– -$292K -8,942 Closed
TCM
104
Tekla Capital Management
Massachusetts
– -$264K -8,083 Closed
SAM
105
Sectoral Asset Management
Quebec, Canada
– -$260K -7,945 Closed
GC
106
Guggenheim Capital
Illinois
– -$240K -7,349 Closed
USAA
107
United Services Automobile Association
Texas
– -$210K -6,417 Closed
Daiwa Securities Group
108
Daiwa Securities Group
Japan
– -$10K -299 Closed
1 2 3 4
5